Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis

References

• Lee Y, Puumala E, Robbins N., et al. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev. 2021;121(6):3390–3411. doi:10.1021/acs.chemrev.0c00199
   PubMed Web of Science ®Google Scholar
• Neppelenbroek KH, Seó RS, Urban VM, et al. Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Dis. 2014;20(4):329–344. doi:10.1111/odi.12123
   Web of Science ®Google Scholar
• Cao B, Wang H, Wu L, et al. Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing. Zhonghua Yi Xue Za Zhi. 2008;88(28):1970–1973.
   Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–163. doi:10.1128/CMR.00029-06
   PubMed Web of Science ®Google Scholar
• Guo LN, Yu SY, Xiao M, et al. Species Distribution and Antifungal Susceptibility of Invasive Candidiasis: a 2016-2017 Multicenter Surveillance Study in Beijing, China. Infect Drug Resist. 2020;13:2443–2452. doi:10.2147/IDR.S255843
   PubMed Web of Science ®Google Scholar
• Yang ZH, Song YG, Li RY, Ten-year Retrospective A. Study of Invasive Candidiasis in a Tertiary Hospital in Beijing. Biomed Environ Sci. 2021;34(10):773–788. doi:10.3967/bes2021.107.
   PubMed Web of Science ®Google Scholar
• Zeng ZR, Tian G, Ding YH, et al. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China. BMC Infect Dis. 2019;19(1):939. doi:10.1186/s12879-019-4588-9.
   PubMed Web of Science ®Google Scholar
• Ken AB, Ma ZH, Xiong DQ, et al. Clinical features of invasive candidiasis and risk factors for Candida bloodstream infection in children: a multicenter study in Urumqi, China. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19(4):414–418. doi:10.7499/j.issn.1008-8830.2017.04.011.
   Google Scholar
• Asadzadeh M, Ahmad S, Al-Sweih N, et al. Rapid and Accurate Identification of Candida albicans and Candida dubliniensis by Real-Time PCR and Melting Curve Analysis. Med Princ Pract. 2018;27(6):543–548. doi:10.1159/000493426
   Web of Science ®Google Scholar
• Dagi HT, Findik D, Senkeles C, et al. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Ann Clin Microbiol Antimicrob. 2016;15(1):36. doi:10.1186/s12941-016-0153-1
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Posteraro B, Lass-Flörl C. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses. 2015;58:2–13. doi:10.1111/myc.12330
   PubMed Web of Science ®Google Scholar
• Ruan SY, Huang YT, Chu CC, et al. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2009;34(3):236–239. doi:10.1016/j.ijantimicag.2009.02.021
   Web of Science ®Google Scholar
• Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305. doi:10.1111/j.1574-6976.2011.00278.x
   PubMed Web of Science ®Google Scholar
• Cleveland AA, Harrison LH, Farley MM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One. 2015;10(3):e0120452. doi:10.1371/journal.pone.0120452
   PubMed Web of Science ®Google Scholar
• Hedayati MT, Tavakoli M, Zakavi F, et al. In vitro antifungal susceptibility of Candida species isolated from diabetic patients. Rev Soc Bras Med Trop. 2018;51(4):542–545. doi:10.1590/0037-8682-0332-2017
   Web of Science ®Google Scholar
• Relloso MS, Nievas J, Fares Taie S, et al. Evaluation of mass spectrometry: MALDI-TOF MS for fast and reliable yeast identification. Rev Argent Microbiol. 2015;47(2):103–107. doi:10.1016/j.ram.2015.02.004
   Web of Science ®Google Scholar
• Maldonado I, Cataldi S, Garbasz C, et al. Identification of Candida yeasts: conventional methods and MALDI-TOF MS. Rev Iberoam Micol. 2018;35(3):151–154. doi:10.1016/j.riam.2018.02.002
   PubMed Web of Science ®Google Scholar
• Croxatto A, Prodhom G, Hom G, et al. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36(2):380–407. doi:10.1111/j.1574-6976.2011.00298.x.
   PubMed Web of Science ®Google Scholar
• Oviaño M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin. 2021;39(4):192–200. doi:10.1016/j.eimc.2020.02.027
   Web of Science ®Google Scholar
• Tsuchida S, Umemura H, Nakayama T. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology. Molecules. 2020;25:20. doi:10.3390/molecules25204775
   Web of Science ®Google Scholar
• Six A, Krajangwong S, Crumlish M, et al. Galleria mellonella as an Infection Model for the Multi-Host Pathogen Streptococcus Agalactiae Reflects Hypervirulence of Strains Associated with Human Invasive. Dis Virulence. 2019;10(1):600–609. doi:10.1080/21505594.2019.1631660
   PubMed Web of Science ®Google Scholar
• Maurer E, Hörtnagl C, Lackner M, et al. Galleria mellonella as a Model System to Study Virulence Potential of Mucormycetes and Evaluation of Antifungal Treatment. Med Mycol. 2019;57(3):351–362. doi:10.1093/mmy/myy042
   Web of Science ®Google Scholar
• de Castro Spadari C, Da Silva de Bastiani FWM, Pisani PBB, de Azevedo Melo AS, Ishida K. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis. Arch Microbiol. 2020;202(4):773–784. doi:10.1007/s00203-019-01789-8
   Web of Science ®Google Scholar
• Ratcliffe NA. Invertebrate immunity--a primer for the non-specialist. Immunol Lett. 1985;10(5):253–270. doi:10.1016/0165-2478(85)90100-2
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Romeo O, Criseo G. First molecular method for discriminating between Candida africana, Candida albicans, and Candida dubliniensis by using hwp1 gene. Diagn Microbiol Infect Dis. 2008;62(2):230–233. doi:10.1016/j.diagmicrobio.2008.05.014
   PubMed Web of Science ®Google Scholar
• Abastabar M, Hosseinpoor S, Hedayati MT, et al. Hyphal wall protein 1 gene: a potential marker for the identification of different Candida species and phylogenetic analysis. Curr Med Mycol. 2016;2(4):1–8. doi:10.18869/acadpub.cmm.2.4.1
   Google Scholar
• CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 4th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Mesa-Arango AC, Forastiero A, Bernal-Martínez L, et al. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med Mycol. 2013;51(5):461–472. doi:10.3109/13693786.2012.737031
   PubMed Web of Science ®Google Scholar
• Kloezen W, van Helvert-van Poppel M, Fahal AH, et al. A Madurella mycetomatis Grain Model in Galleria mellonella Larvae. PLoS Negl Trop Dis. 2015;9(7):e0003926. doi:10.1371/journal.pntd.0003926
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics. 2020;9:6. doi:10.3390/antibiotics9060312
   Web of Science ®Google Scholar
• Soulountsi V, Schizodimos T, Kotoulas SC. Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible? Infection. 2021;49(6):1107–1131. doi:10.1007/s15010-021-01640-7
   PubMed Web of Science ®Google Scholar
• Wang SA, Jia JH, Bai FY. Candida alocasiicola sp. nov., Candida hainanensis sp. nov., Candida heveicola sp. nov. and Candida musiphila sp. nov., novel anamorphic, ascomycetous yeast species isolated from plants. Antonie Van Leeuwenhoek. 2008;94(2):257–265. doi:10.1007/s10482-008-9238-y
   Web of Science ®Google Scholar
• Alam MZ, Alam Q, Jiman-Fatani A, et al. Candida identification: a journey from conventional to molecular methods in medical mycology. World J Microbiol Biotechnol. 2014;30(5):1437–1451. doi:10.1007/s11274-013-1574-z
   Web of Science ®Google Scholar
• Ambaraghassi G, Dufresne PJ, Dufresne SF, et al. Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study. J Clin Microbiol. 2019;57(11):548. doi:10.1128/JCM.00884-19
   Web of Science ®Google Scholar
• Dekkers B, Veringa A, Marriott D, et al. Invasive Candidiasis in the Elderly: considerations for Drug Therapy. Drugs Aging. 2018;35(9):781–789. doi:10.1007/s40266-018-0576-9
   PubMed Web of Science ®Google Scholar
• Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi:10.1001/jama.2009.1754
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Kett DH, Wauters J. Defining standards of CARE for invasive fungal diseases in the ICU. J Antimicrob Chemother. 2019;74(Suppl2):ii9–ii15. doi:10.1093/jac/dkz038
   PubMed Web of Science ®Google Scholar
• Bassetti M, Giacobbe DR, Vena A, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project[J]. Crit Care. 2019;23(1):219. doi:10.1186/s13054-019-2497-3
   Web of Science ®Google Scholar
• Bassetti M, Azoulay E, Kullberg BJ, et al. EORTC/MSGERC Definitions of Invasive Fungal Diseases: summary of Activities of the Intensive Care Unit Working Group[J]. Clin Infect Dis. 2021;72(Suppl 2):S121–S127. doi:10.1093/cid/ciaa1751
   Web of Science ®Google Scholar
• McCarty TP, White CM, Pappas PG. Candidemia and Invasive Candidiasis[J]. Infect Dis Clin North Am. 2021;35(2):389–413. doi:10.1016/j.idc.2021.03.007
   PubMed Web of Science ®Google Scholar
• Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide[J]. Clin Microbiol Infect. 2019;25(7):792–798. doi:10.1016/j.cmi.2019.03.028
   PubMed Web of Science ®Google Scholar
• Sadeghi-Ghadi Z, Vaezi A, Ahangarkani F, et al. Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates[J]. J Mycol Med. 2020;30(4):101014. doi:10.1016/j.mycmed.2020.101014
   PubMed Web of Science ®Google Scholar
• Arendrup MC. Epidemiology of invasive candidiasis[J]. Curr Opin Crit Care. 2010;16(5):445–452. doi:10.1097/MCC.0b013e32833e84d2
   PubMed Web of Science ®Google Scholar
• Staniszewska M. Virulence Factors in Candida species[J]. Curr Protein Pept Sci. 2020;21(3):313–323. doi:10.2174/1389203720666190722152415
   Web of Science ®Google Scholar
• Lohse MB, Gulati M, Johnson AD, et al. Development and regulation of single- and multi-species Candida albicans biofilms[J]. Nat Rev Microbiol. 2018;16(1):19–31. doi:10.1038/nrmicro.2017.107
   PubMed Web of Science ®Google Scholar
• Delavy M, Dos Santos AR, Heiman CM, et al. Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays[J]. Front Cell Infect Microbiol. 2019;9:19. doi:10.3389/fcimb.2019.00019
   PubMed Web of Science ®Google Scholar
• Meena S, Mohanty A, Kaistha N, et al. Comparative Assessment of Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF-MS) and Conventional Methods in the Identification of Clinically Relevant Yeasts[J]. Cureus. 2021;13(6):e15607. doi:10.7759/cureus.15607
   Web of Science ®Google Scholar
• Murphy SE, Drug Resistance BT. Novel Therapeutic Approaches in Invasive Candidiasis[J]. Front Cell Infect Microbiol. 2021;11:759408. doi:10.3389/fcimb.2021.759408
   Web of Science ®Google Scholar
• Mohammadi F, Ghasemi Z, Familsatarian B, et al. Relationship between antifungal susceptibility profile and virulence factors in Candida albicans isolated from nail specimens[J]. Rev Soc Bras Med Trop. 2020;53:e20190214. doi:10.1590/0037-8682-0214-2019
   Web of Science ®Google Scholar
• Nasri E, Fakhim H, Vaezi A, et al. Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients. Mycoses. 2019;62(5):434–440. doi:10.1111/myc.12898
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Javidnia J, et al. Candida africana vulvovaginitis: prevalence and geographical distribution. J Mycol Med. 2020;30(3):100966. doi:10.1016/j.mycmed.2020.100966
   PubMed Web of Science ®Google Scholar
• Mello VG, Escudeiro H, Weckwerth A, et al. Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients. Mycopathologia. 2021;186(1):71–80. doi:10.1007/s11046-020-00509-x
   Web of Science ®Google Scholar
• Cutuli MA, Petronio Petronio G, Vergalito F, et al. Galleria mellonella as a consolidated in vivo model hosts: new developments in antibacterial strategies and novel drug testing. Virulence. 2019;10(1):527–541. doi:10.1080/21505594.2019.1621649
   PubMed Web of Science ®Google Scholar
• Borman AM, Szekely A, Johnson EM. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere. 2016;1(4):448. doi:10.1128/mSphere.00189-16
   Web of Science ®Google Scholar